belantamab mafodotin
Sign in to saveAlso known as Blenrep, belantamab mafodotin-blmf, GSK2857916
pharmaceutical drug
In the Vinony graph
Within Vinony's link graph, belantamab mafodotin is referenced by 348 other articles, and connects out to influenza vaccine, meningococcal vaccine and DPT vaccine.
It sits within the topics Antibody-drug conjugates, Chemical pages without ChemSpiderID and Drugs developed by GSK plc.
Its subject is documented across 8 Wikipedia language editions.
Medication
- Generic name
- Belantamab Mafodotin
- Brand names
- Blenrep
- Active ingredients
- belantamab
- Route
- Intravenous
- Type
- Human Prescription Drug
- Manufacturer
- GlaxoSmithKline LLC
Indications: 1 INDICATIONS AND USAGE BLENREP is indicated in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy, including a proteasome inhibitor and an immunomodulatory agent. BLE… (per FDA label)
Clinical Trials
64 registered- PHASE1/PHASE2RECRUITINGCombination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple MyelomaUniversitätsklinikum Hamburg-Eppendorf · NCT05853965
- PHASE1/PHASE2ACTIVE_NOT_RECRUITINGStudy of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to LenalidomidePETHEMA Foundation · NCT05060627
- PHASE2RECRUITINGMinimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaM.D. Anderson Cancer Center · NCT05091372
- PHASE1/PHASE2RECRUITINGA Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination TreatmentsGlaxoSmithKline · NCT05714839
- PHASE1/PHASE2TERMINATEDBelantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple MyelomaUniversity of Maryland, Baltimore · NCT04896658
- PHASE1/PHASE2ACTIVE_NOT_RECRUITINGSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMMGlaxoSmithKline · NCT07150091
Wikidata facts
- Instance of
- monoclonal antibody
Show 1 more fact
- legal status (medicine)
- boxed warning
Sources (1)
via Wikidata · CC0